ClinicalTrials.Veeva

Menu

The Expression of Aquaporin 3, 8 and 9 in Placenta in Normal and Preeclamptic Pregnancies: Perinatal and Neonatal Outcomes.

R

Rakhshanda Aslanova

Status

Unknown

Conditions

Preeclampsia

Study type

Observational

Funder types

Other

Identifiers

NCT02045316
RA-221281

Details and patient eligibility

About

The etiologic agent responsible for the development of preeclampsia remains unknown. Aquaporins, members of integral membrane proteins, are responsible of water molecules movements through the plasma membrane channels, energy metabolism and associated with changes in cellular volume during apoptosis.

İn such placental pathology as preeclampsia, characterized with superficial implantation and increased apoptosis leading to a relative hypoxia between mother and fetus, the hypothesis of aquaporins important role in energy homeostasis and apoptosis maybe suggested.

Full description

The investigators are carrying out a study of 210 pregnant women , from whom 105 will have pregnancy complicated with preeclampsia and 105 with normal pregnancy.

The investigators aim is to investigate the role of the placenta, umbilical cord and amniotic membrane aquaporin expression in etiopathogenesis of preeclampsia. The investigators will compare aquaporin levels in preeclamptic and normal placentas, umbilical cords and amniotic membranes , and investigate relation between aquaporin levels and perinatal ( maternal blood pressure, proteinuria, maternal-fetal doppler ultrasound, amniotic fluid index, fetal intrauterine growth) and neonatal ( Apgar score, biometry, complications) finding.

Enrollment

210 estimated patients

Sex

Female

Ages

17 to 45 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Preeclamptic pregnants
  • Normal non-complicated pregnants

Exclusion criteria

-Pregnants with another obstetric complications

Trial design

210 participants in 2 patient groups

Preeclamptic pregnants
Description:
pregnants with preeclampsia
Normal pregnants
Description:
pregnants without obstetric complications

Trial contacts and locations

1

Loading...

Central trial contact

Rakhshanda Aslanova, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems